Sattar N, Lee MMY, Kristensen SL, Branch KRH, Del Prato S, Khurmi NS, Lam CSP, Lopes RD, McMurray JJV, Pratley RE, et al: Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
Targeting adipose tissue in the treatment of obesity-associated diabetes
Supplementary Materials Data Availability Statement The data presented in this study are available on request from the corresponding author.
Forty received oral semaglutide, 32 received injectable semaglutide, 12 received dulaglutide, while 8 received liraglutide (see Figure 2)
Monitor blood sugar if diabetic/pre-diabetic If hypoglycemia occurs: Consume 15g fast-acting carbs immediately Wait 15 minutes Check symptoms